287 related articles for article (PubMed ID: 17723087)
1. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem.
Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M
Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087
[TBL] [Abstract][Full Text] [Related]
2. Is it safe to use carbapenems in patients with a history of allergy to penicillin?
Sodhi M; Axtell SS; Callahan J; Shekar R
J Antimicrob Chemother; 2004 Dec; 54(6):1155-7. PubMed ID: 15486083
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams.
Schiavino D; Nucera E; Lombardo C; Decinti M; Pascolini L; Altomonte G; Buonomo A; Patriarca G
Allergy; 2009 Nov; 64(11):1644-8. PubMed ID: 19392998
[TBL] [Abstract][Full Text] [Related]
4. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
5. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Kuo BI; Fung CP; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
[TBL] [Abstract][Full Text] [Related]
6. Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin.
Bauer SL; Wall GC; Skoglund KJ; Peters LK
J Allergy Clin Immunol; 2004 Jan; 113(1):173-5. PubMed ID: 14713926
[No Abstract] [Full Text] [Related]
7. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.
Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D
J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688
[TBL] [Abstract][Full Text] [Related]
9. Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.
McConnell SA; Penzak SR; Warmack TS; Anaissie EJ; Gubbins PO
Clin Infect Dis; 2000 Dec; 31(6):1512-4. PubMed ID: 11096026
[TBL] [Abstract][Full Text] [Related]
10. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Nakane T; Tamura K; Hino M; Tamaki T; Yoshida I; Fukushima T; Tatsumi Y; Nakagawa Y; Hatanaka K; Takahashi T; Akiyama N; Tanimoto M; Ohyashiki K; Urabe A; Masaoka T; Kanamaru A;
J Infect Chemother; 2015 Jan; 21(1):16-22. PubMed ID: 25239059
[TBL] [Abstract][Full Text] [Related]
11. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
12. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
Shorr AF; Zadeikis N; Jackson WL; Ramage AS; Wu SC; Tennenberg AM; Kollef MH
Clin Infect Dis; 2005 Feb; 40 Suppl 2():S123-9. PubMed ID: 15712100
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
Unertl K; Lenhart FP; Ruckdeschel G
Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
[TBL] [Abstract][Full Text] [Related]
16. Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
Romanelli G; Cravarezza P; Pozzi A; Franchino L; Ravizzola G; Zulli R; Donati P; Prometti P; Grassi V
J Chemother; 2002 Dec; 14(6):609-17. PubMed ID: 12583553
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care.
Edwards SJ; Campbell HE; Plumb JM
Eur J Health Econ; 2006 Mar; 7(1):72-8. PubMed ID: 16429296
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of meropenem in children with IgE-mediated hypersensitivity to penicillins.
Atanasković-Marković M; Gaeta F; Medjo B; Viola M; Nestorović B; Romano A
Allergy; 2008 Feb; 63(2):237-40. PubMed ID: 18186815
[TBL] [Abstract][Full Text] [Related]
19. Imipenem in patients with immediate hypersensitivity to penicillins.
Romano A; Viola M; Guéant-Rodriguez RM; Gaeta F; Pettinato R; Guéant JL
N Engl J Med; 2006 Jun; 354(26):2835-7. PubMed ID: 16807429
[No Abstract] [Full Text] [Related]
20. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
